(d) REPORT.—A report summarizing the Con-
ference’s findings and recommendations shall be sub-
mitted to the Congress not later than June 30, 2011. 
(e) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there is authorized 
to be appropriated $500,000 for each of fiscal years 2010 
and 2011. 
SEC. 3. PAIN RESEARCH AT NATIONAL INSTITUTES OF 
HEALTH. 
Part B of title IV of the Public Health Service Act 
(42 U.S.C. 284 et seq.) is amended by adding at the end 
the following: 
‘‘SEC. 409J. PAIN RESEARCH. 
‘‘(a) RESEARCH INITIATIVES.— 
‘‘(1) IN GENERAL.—The Director of NIH is en-
couraged to continue and expand, through the Pain 
Consortium, an aggressive program of basic and 
clinical research on the causes of and potential treat-
ments for pain. 
‘‘(2) ANNUAL
RECOMMENDATIONS.—Not less 
than annually, the Pain Consortium, in consultation 
with the Division of Program Coordination, Plan-
ning, and Strategic Initiatives, shall develop and 
submit to the Director of NIH recommendations on 
appropriate pain research initiatives that could be 
VerDate Nov 24 2008 
03:16 Jan 30, 2009
Jkt 079200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H756.IH
H756
wwoods2 on PRODPC68 with BILLS
undertaken with funds reserved under section 
402A(c)(1) for the Common Fund or otherwise 
available for such initiatives. 
‘‘(3) DEFINITION.—In this subsection, the term 
‘Pain Consortium’ means the Pain Consortium of 
the National Institutes of Health or a similar trans- 
National Institutes of Health coordinating entity 
designated by the Secretary for purposes of this sub-
section. 
‘‘(b) INTERAGENCY PAIN RESEARCH COORDINATING 
COMMITTEE.— 
‘‘(1) ESTABLISHMENT.—The Secretary shall es-
tablish not later than 1 year after the date of the 
enactment of this section and as necessary maintain 
a committee, to be known as the Interagency Pain 
Research Coordinating Committee (in this section 
referred to as the ‘Committee’), to coordinate all ef-
forts within the Department of Health and Human 
Services and other Federal agencies that relate to 
pain research. 
‘‘(2) MEMBERSHIP.— 
‘‘(A) IN GENERAL.—The Committee shall 
be composed of the following voting members: 
‘‘(i) Not more than 7 voting Federal 
representatives as follows: 
VerDate Nov 24 2008 
03:16 Jan 30, 2009
Jkt 079200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H756.IH
H756
wwoods2 on PRODPC68 with BILLS
‘‘(I) The Director of the Centers 
for Disease Control and Prevention. 
‘‘(II) The Director of the Na-
tional Institutes of Health and the di-
rectors of such national research insti-
tutes and national centers as the Sec-
retary determines appropriate. 
‘‘(III) The heads of such other 
agencies of the Department of Health 
and Human Services as the Secretary 
determines appropriate. 
‘‘(IV) Representatives of other 
Federal agencies that conduct or sup-
port pain care research and treat-
ment, including the Department of 
Defense and the Department of Vet-
erans Affairs. 
‘‘(ii) 12 additional voting members ap-
pointed under subparagraph (B). 
‘‘(B) ADDITIONAL MEMBERS.—The Com-
mittee shall include additional voting members 
appointed by the Secretary as follows: 
‘‘(i) 6 members shall be appointed 
from among scientists, physicians, and 
other health professionals, who— 
VerDate Nov 24 2008 
03:16 Jan 30, 2009
Jkt 079200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H756.IH
H756
wwoods2 on PRODPC68 with BILLS
‘‘(I) are not officers or employees 
of the United States; 
‘‘(II) 
represent 
multiple 
dis-
ciplines, including clinical, basic, and 
public health sciences; 
‘‘(III) represent different geo-
graphical 
regions 
of 
the 
United 
States; and 
‘‘(IV) are from practice settings, 
academia, manufacturers or other re-
search settings; and 
‘‘(ii) 6 members shall be appointed 
from members of the general public, who 
are representatives of leading research, ad-
vocacy, and service organizations for indi-
viduals with pain-related conditions. 
‘‘(C) NONVOTING
MEMBERS.—The Com-
mittee shall include such nonvoting members as 
the Secretary determines to be appropriate. 
‘‘(3) CHAIRPERSON.—The voting members of 
the Committee shall select a chairperson from 
among such members. The selection of a chairperson 
shall be subject to the approval of the Director of 
NIH. 
VerDate Nov 24 2008 
03:16 Jan 30, 2009
Jkt 079200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H756.IH
H756
wwoods2 on PRODPC68 with BILLS
‘‘(4) MEETINGS.—The Committee shall meet at 
the call of the chairperson of the Committee or upon 
the request of the Director of NIH, but in no case 
less often than once each year. 
‘‘(5) DUTIES.—The Committee shall— 
‘‘(A) develop a summary of advances in 
pain care research supported or conducted by 
the Federal agencies relevant to the diagnosis, 
prevention, and treatment of pain and diseases 
and disorders associated with pain; 
‘‘(B) identify critical gaps in basic and 
clinical research on the symptoms and causes of 
pain; 
‘‘(C) make recommendations to ensure that 
the activities of the National Institutes of 
Health and other Federal agencies, including 
the Department of Defense and the Department 
of Veteran Affairs, are free of unnecessary du-
plication of effort; 
‘‘(D) make recommendations on how best 
to disseminate information on pain care; and 
‘‘(E) make recommendations on how to ex-
pand partnerships between public entities, in-
cluding Federal agencies, and private entities to 
expand collaborative, cross-cutting research. 
VerDate Nov 24 2008 
03:16 Jan 30, 2009
Jkt 079200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H756.IH
H756
wwoods2 on PRODPC68 with BILLS